Table 2.
Levels of Serum KAI1 and Vascular Endothelial Growth Factor in 160 Patients with Liver Diseases
| Group | No. | KAI1 | VEGF | ||||
|---|---|---|---|---|---|---|---|
|
|
|
||||||
| χ̄ ±SD, pg/mL | t | p-value | χ̄ ±SD, pg/mL | t | p-value | ||
| HCC | 86 | 45.391±6.376 | 276.894±73.547 | ||||
| Cirrhosis | 38 | 197.365±53.697 | 25.966* | <0.001* | 156.473±60.034 | 8.866† | <0.001† |
| Hepatitis | 36 | 221.597±49.768 | 32.386* | <0.001* | 97.394±21.765 | 14.352† | <0.001† |
| Normal control | 30 | 315.164±61.254 | 40.542* | <0.001* | 54.368±9.847 | 16.475† | <0.001† |
VEGF, vascular endothelial growth factor; SD, standard deviation; HCC, hepatocellular carcinoma.
*
Versus the level of serum KAI1 in the HCC group;
†
Versus the level of serum VEGF in the HCC group.